SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian Cancer

NEXT STORY
Global Health and Wellness Market to Garner Revenue of $6,543.4 Million at a CAGR of 4.8% from 2019-2026 Exclusive Report [Pages-110] by Research Dive
PREV STORY
Insights on the Motor Vehicles Global Market to 2030 – Identify Growth Segments for Investment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors

author_avatar
NASDAQ Market News

Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting

author_avatar
NASDAQ Market News

Mateon Therapeutics Announces Termination of FOCUS Study in Ovarian Cancer and Restructuring to Prioritize OXi4503 for AML

Company to terminate FOCUS study due to lack of clear efficacy signal in the ...

author_avatar
NASDAQ Market News